By continuing to use the site you agree to our Privacy & Cookies policy

Cochrane review questions benefit of Tamiflu

Ministers should review the use of a widely used anti-flu medication, researchers have said after their review questioned the efficacy of the drug oseltamivir (Tamiflu).

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units 
or

newsletterpromo